
    
      Specific Aims:

      Aim # 1: Determine the efficacy of VSL #3 on IBS symptoms in GW veterans.

      Hypothesis: Treatment with VSL #3 compared to placebo will improve global and individual
      symptoms of IBS

      Aim #2 Determine the efficacy VSL #3 in reducing non-intestinal symptoms of IBS (fatigue,
      joint pain, insomnia, general stiffness and headache).

      Hypothesis: Treatment with VSL #3 compared to placebo will improve non-intestinal symptoms of
      IBS in GW veterans.

      Aim #3 Determine whether changes in gut flora and plasma cytokines correlate with treatment
      response in GW veterans.
    
  